← All trials
NCT06133634
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 25, 2023
- Primary completion
- Mar 31, 2026
- Completion date
- Mar 31, 2027
- First posted
- Nov 15, 2023
- Last posted
- Nov 15, 2023
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Colorado, BoulderLead sponsor
- American Heart AssociationCollaborator
- University of Colorado, BoulderOverall official - principal investigator
- University of Colorado, BoulderReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.